文献速递腹部技术与安全PETCT

18F-FDG PET/CT影像组学机器学习预测结直肠癌RAS突变及预后分层

Machine learning models using 18F-FDG PET/CT radiomics for RAS mutation prediction and prognostic stratification in colorectal cancer.
PubMed 文献 · Br J Radiol · 2026-01-01

回顾性纳入90例结直肠癌患者,基于治疗前18F-FDG PET/CT提取49个影像组学特征,结合10个临床变量,用AutoGluon机器学习框架建立预测RAS突变模型。影像组学模型AUC为0.675,生存分析显示基于机器学习预测的RAS状态与真实RAS状态的风险分层高度相关。

要点

  • 影像组学机器学习预测RAS突变AUC为0.675,属中等水平,不宜单独替代基因检测
  • 基于ML预测RAS状态与真实RAS状态的生存风险评分高度相关,有预后分层价值
  • NGTDM_Complexity、峰度、偏度为RAS预测关键影像组学特征

核心结论

  • 影像组学机器学习模型预测RAS突变表现中等,AUC为0.675
  • 基于ML预测RAS状态的预后分层能力与基于真实基因谱的分层相当
  • 18F-FDG PET影像组学可能是结直肠癌基因谱无创评估与预后判断的潜在工具,尚需进一步验证

研究设计与样本

  • 回顾性研究,纳入90例结直肠癌患者,平均年龄64岁,其中60例男性
  • 均接受治疗前18F-FDG PET/CT检查,从PET图像提取影像组学特征
  • 分析10个临床变量和49个影像组学特征,采用AutoGluon机器学习框架建立临床、影像组学和联合模型
  • 采用10折交叉验证评估RAS突变预测性能,用SHAP分析评估可解释性
  • 生存结局采用RSF模型评估,基于真实RAS和ML预测RAS分别计算疾病进展风险评分

关键影像表现/征象

  • SHAP分析显示NGTDM_Complexity、峰度和偏度为RAS突变预测的关键影像组学特征
  • 两个模型的生存曲线表现相当

诊断标准与关键数值

  • 影像组学机器学习模型预测RAS突变的AUC为0.675
  • 基于真实RAS状态的生存分析C指数为0.685,基于ML预测RAS状态的C指数为0.675
  • 两个模型的风险评分相关系数r为0.99,ρ为0.98

临床应用与阅片要点

  • 18F-FDG PET影像组学可作为RAS突变状态的无创预筛工具,但中等预测效能不足以取代基因检测
  • 即使预测RAS状态不完全准确,仍可用于结直肠癌患者的风险分层与预后评估
  • 关注PET纹理复杂度、峰度和偏度等特征可能反映肿瘤异质性与基因突变状态

局限性

  • 回顾性单中心研究,样本量仅90例,模型需外部验证
  • 影像组学模型预测RAS突变AUC为0.675,表现为中等水平,临床替代基因检测的效能有限

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate a machine learning (ML) model that integrates clinical data and 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG)-PET radiomic features for predicting RAS mutation status and prognosis in patients with colorectal cancer (CRC).

METHODS: This retrospective study included 90 patients (mean age, 64 years, 60 men) with CRC who underwent pretreatment 18F-FDG-PET/CT. Radiomic features were extracted from PET images. Ten clinical variables and 49 radiomic features were analyzed. Using the AutoGluon ML framework, 3 models (clinical, radiomics, and combined) were developed with 10-fold cross-validation. RAS mutation prediction was evaluated by the AUC, and interpretability was assessed using SHAP analysis. Survival outcomes were evaluated using a RSF model, and risk scores for disease progression were calculated based on true RAS and ML-predicted RAS models.

RESULTS: The radiomics ML model demonstrated the highest performance with an AUC of 0.675. SHAP analysis identified NGTDM_Complexity, kurtosis, and skewness as key contributors. For survival analysis, the C-indices based on true and ML-predicted RAS status were 0.685 and 0.675, respectively. A strong correlation was observed between the risk scores derived from the 2 models (r = 0.99, ρ = 0.98). Kaplan-Meier analysis demonstrated clear separation between high- and low-risk groups for both models (log-rank P < .01), with comparable survival curves.

CONCLUSION: Although the radiomics-based ML model demonstrated moderate performance in predicting RAS mutation status, it provided prognostic stratification comparable to that based on true genetic profiles.

ADVANCES IN KNOWLEDGE: 18F-FDG PET-based radiomics with ML may have potential as a noninvasive approach for genetic profiling and prognostic assessment in CRC, although further validation is required.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Nakajo, Hirahara, Baba, et al. Machine learning models using 18F-FDG PET/CT radiomics for RAS mutation prediction and prognostic stratification in colorectal cancer. Br J Radiol. 2026. PMID: 42397208. doi:10.1093/bjr/tqag129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。